two new investigational drugs for type 2 diabetes, Januvia and Galvus
July 2006
There's lots of buzz coming out of the latest American Diabetes Assoc meeting about two new investigational drugs for type 2 diabetes, Januvia and Galvus.
They're in a new class...DPP-4 inhibitors. They increase incretin. Watch for them later this fall and next year.
If you need info now, get our Detail-Document.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote